New genomic research shows why testing malaria vaccines in the clinic is as rigorous as natural exposure in the field

Call to count breast milk in food statistics
19 July 2022
Teen with heart defect wants to help others like her
19 July 2022

New genomic research shows why testing malaria vaccines in the clinic is as rigorous as natural exposure in the field

Malaria is the deadliest mosquito-borne parasitic infection of humans. In 2021, after a century of research, the World Health Organization (WHO) approved the world’s first malaria vaccine. That vaccine reduces the incidence of malaria infections in young children aged 5-17 months by only 30 percent, meaning that it remains critical to continue developing and testing more effective vaccines.

Comments are closed.